https://orcid.org/0000-0002-6359-5334
References
- Moran GP, Coleman DC, Sullivan DJ, et al. Candida albicans versus Candida dubliniensis: why is C. albicans more pathogenic? Int J Microbiol. 2012;2012:205921.
- Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol Am Soc Microbiol J. 1998 Feb 1;36(2):329–334. .
- Derek J. Sullivan, Gary P. Moran, David C. Coleman, Candida dubliniensis: Ten years on, FEMS Microbiology Letters, Volume 253, Issue 1, December 2005, Pages 9–17, https://doi.org/10.1016/j.femsle.2005.09.015
- Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol. 2005;26:540–547.
- Khan Z, Ahmad S, Joseph L, et al. Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. PloS One. 2012;7(3):e32952.
- Benedetti VP, Savi DC, Aluizio R, et al. Analysis of the genetic diversity of Candida isolates obtained from diabetic patients and kidney transplant recipients. Mem Inst Oswaldo Cruz. 2016;(7).
- Colombo AL, Guimarães T, Camargo LF, et al. Brazilian guidelines for the management of candidiasis: a joint meeting report of three medical societies: sociedade Brasileira de Infectologia, SociedadePaulista de Infectologia, SociedadeBrasileira de Medicina Tropical. Braz J InfectDis.[online]. 2013; 17(3):283–312. https://doi.org/10.1016/j.bjid.2013.02.001..
- Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drug susceptibility of oral Candida dubliniensis isolates from HIV-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother. 1997;41:617–623.
- Moran GP, Coleman DC, Sullivan DJ. Candida albicans versus Candida dubliniensis: why is C. albicans more pathogenic? Int J Microbiol. 2011. Epub 2011 Sep 4. DOI:10.115/2012/:205921
- Stokes C, Moran GP, Spiering MJ, et al. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol. 2007;44:920–931.
- Phua AI-H, Hon KY, Holt A, et al. Candida catheter-related bloodstream infection in patients on home parenteral nutrition - Rates, risk factors, outcomes, and management. Clin Nutr ESPEN. 2019;31:1–9.
- Aghdam M, Reza F, Sund S. Invasive esophageal candidiasis with chronic mediastinal abscess and fatal pneumomediastinum. Am J Case Rep. 2016 Jul 8;17: 466–471. .
- Piubelli MLM, Felipe-Silva A, Kanegae MY, et al. Fatal necrotizing Candida esophagitis in a patient with leukocytoclastic cutaneous vasculitis and ankylosing spondylitis. Autops Case Rep. 2019 Mar 22;9(2):e2018070. .
- Al-Shawwa B, D’Andrea L, Quintero D, et al. Candida esophageal perforation and esophagopleural fistula: a case report. J Med Case Rep. 2008 Jun 17;2(1):209. .
- LEFKOWITZ M, ELSAS LJ, LEVINE RJ. Candida infection complicating peptic esophageal ulcer: infection in an aortic-esophageal fistula. Arch Intern Med. 1964;113(5):672–675.
- Riquelme M, Aguirre J, Bartnicki-García S, et al. Fungal morphogenesis, from the polarized growth of hyphae to complex reproduction and infection structures. Microbiol Mol Biol Rev. 2018;82(2):e00068–17.